United Kingdom· GB-APID-44930311000001106
Lytgobi 4mg tablets
A futibatinib product containing futibatinib, registered in United Kingdom by Taiho Pharma Europe Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Futibatinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EN04 (futibatinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Futibatinib · ATC L01EN04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of futibatinib costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.36 in France to $366.73 in Switzerland — a ×1007 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Futibatinib · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$366.73
- FR France$0.36
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Futibatinib
- Manufacturer
- Taiho Pharma Europe Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EN04
- ATC class
- Futibatinib
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin5061069970012
- gtin5061069970029
- gtin08470007632221
- gtin5061069970005
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Futibatinib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLYTGOBITAIHO PHARMACEUTICAL CO., LTD.
- SwitzerlandLytgobi 4 mg, FilmtablettenTaiho Oncology Europe GmbH
- CzechiaLYTGOBITaiho Pharma Netherlands B.V., Amsterdam
- FranceLYTGOBI 4 mg, comprimé pelliculéTAIHO PHARMA NETHERLANDS (PAYS-BAS)
- BelgiumLytgobi 4 mgTaiho Pharma Netherlands
- IcelandLytgobiTaiho Pharma Netherlands B.V.
- NetherlandsLytgobi 4 mg filmomhulde tablettenTaiho Pharma Netherlands B.V.
- PolandLytgobiTaiho Pharma Netherlands B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3ef56ed-fc43-48e8-8695-2c38d85fbc93 GET /v1/drugs/b3ef56ed-fc43-48e8-8695-2c38d85fbc93?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44930311000001106",
"desc": "Lytgobi 4mg tablets (Taiho Pharma Europe Ltd)",
"form": "Oral tablet",
"vpid": "44930911000001107",
"source": "dmd",
"vtm_id": "44930511000001100",
"strength": "4 mg",
"substance": "Futibatinib",
"ingredient": "Futibatinib",
"supplier_code": "44128511000001102"
}See everything about futibatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.